Suppr超能文献

允许性高碳酸血症:在肺保护性通气策略中的作用。

Permissive hypercapnia: role in protective lung ventilatory strategies.

作者信息

Ni Chonghaile Martina, Higgins Brendan, Laffey John G

机构信息

Department of Anaesthesia, Clinical Sciences Institute and National Centre for Biomedical Engineering Sciences, National University of Ireland, Galway, Ireland.

出版信息

Curr Opin Crit Care. 2005 Feb;11(1):56-62. doi: 10.1097/00075198-200502000-00009.

Abstract

PURPOSE OF REVIEW

Hypercapnia is a central component of current protective ventilatory strategies. This review aims to present and interpret data from recent clinical and experimental studies relating to hypercapnia and its role in protective ventilatory strategies.

RECENT FINDINGS

Increasing clinical evidence supports the use of permissive hypercapnia, particularly in acute lung injury/acute respiratory distress syndrome, status asthmaticus, and neonatal respiratory failure. However, there are no clinical data examining the contribution of hypercapnia per se to protective ventilatory strategies. Recent experimental studies provide further support for the concept of therapeutic hypercapnia, whereby deliberately elevated PaCO2 may attenuate lung and systemic organ injury. CO2 administration attenuates experimental acute lung injury because of adverse ventilatory strategies, mesenteric ischemia reperfusion, and pulmonary endotoxin instillation. Hypercapnic acidosis attenuates key effectors of the inflammatory response and reduces lung neutrophil infiltration. At the genomic level, hypercapnic acidosis attenuates the activation of nuclear factor-kappaB, a key regulator of the expression of multiple genes involved in the inflammatory response. The physiologic effects of hypercapnia, both beneficial and potentially deleterious, are increasingly well understood. In addition, reports suggest that humans can tolerate extreme levels of hypercapnia for relatively prolonged periods without adverse effects.

SUMMARY

The potential for hypercapnia to contribute to the beneficial effects of protective lung ventilatory strategies is clear from experimental studies. However, the optimal ventilatory strategy and the precise contribution of hypercapnia to this strategy remain unclear. A clearer understanding of its effects and mechanisms of action is central to determining the safety and therapeutic utility of hypercapnia in protective lung ventilatory strategies.

摘要

综述目的

高碳酸血症是当前保护性通气策略的核心组成部分。本综述旨在呈现并解读近期有关高碳酸血症及其在保护性通气策略中作用的临床和实验研究数据。

最新发现

越来越多的临床证据支持采用允许性高碳酸血症,尤其是在急性肺损伤/急性呼吸窘迫综合征、哮喘持续状态及新生儿呼吸衰竭中。然而,尚无临床数据检验高碳酸血症本身对保护性通气策略的作用。近期的实验研究为治疗性高碳酸血症的概念提供了进一步支持,即故意提高动脉血二氧化碳分压(PaCO2)可能减轻肺和全身器官损伤。给予二氧化碳可减轻因不良通气策略、肠系膜缺血再灌注及肺内注入内毒素所致的实验性急性肺损伤。高碳酸性酸中毒可减弱炎症反应的关键效应器并减少肺内中性粒细胞浸润。在基因组水平,高碳酸性酸中毒可减弱核因子-κB的激活,核因子-κB是参与炎症反应的多个基因表达的关键调节因子。高碳酸血症的生理效应,无论是有益的还是潜在有害的,都越来越为人所了解。此外,报告表明人类能够在相对较长时间内耐受极高水平的高碳酸血症而无不良影响。

总结

从实验研究来看,高碳酸血症对保护性肺通气策略有益作用的可能性是明确的。然而,最佳通气策略以及高碳酸血症对该策略的确切作用仍不明确。更清楚地了解其效应和作用机制对于确定高碳酸血症在保护性肺通气策略中的安全性和治疗效用至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验